Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.
Nucera, Carmelo, Matthew A Nehs, Sushruta S Nagarkatti, Peter M Sadow, Michal Mekel, Andrew H Fischer, Paul S Lin, et al. 2011. “Targeting BRAFV600E With PLX4720 Displays Potent Antimigratory and Anti-Invasive Activity in Preclinical Models of Human Thyroid Cancer.”. The Oncologist 16 (3): 296-309.